University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois

University of Chicago Medicine Comprehensive Cancer Center is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Chicago Medicine Comprehensive Cancer Center has participated in 29 clinical trials with 20 currently active.

Therapeutic areas: Prostate Cancer, Adult Patients Who Are Receiving Oncologic Care, Head and Neck Cancer.

Sponsors: University of Chicago, Sumitomo Pharma America, Inc., Cogent Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago Medicine Comprehensive Cancer Center?

University of Chicago Medicine Comprehensive Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago Medicine Comprehensive Cancer Center conducted?

University of Chicago Medicine Comprehensive Cancer Center has 29 clinical trials on record, with 20 currently active. Their work covers Prostate Cancer, Adult Patients Who Are Receiving Oncologic Care, Head and Neck Cancer.

Is University of Chicago Medicine Comprehensive Cancer Center accredited by Crixeo Health?

Yes — University of Chicago Medicine Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Chicago Medicine Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.